AnalystBook Research · Company Intelligence

DENTSPLY SIRONA Inc.

XRAYNasdaq

Built from DENTSPLY SIRONA Inc.'s own SEC filings · updates as new filings land · sources cited throughout

or browse all covered companies

DENTSPLY SIRONA Inc.: Revenue declined 3.0% to $3.68B from $3.793B. The net loss narrowed from $910M to $598M. Free cash flow declined 63.0% to $104M from $281M. Operating margin expanded 1170 bps to -11.47%. DENTSPLY SIRONA Inc.'s annual comparison also shows inventory grew faster than revenue; the balance-sheet screen falls in the distress range and requires business-model context.

The read at a glance✓ Audited against SEC data
  • GrowthRevenue declined 3.0%Watch
  • ProfitabilityThe net loss narrowed from $910M to $598MOK
  • Cash flowFree cash flow declined 63.0% to $104M from $281MWatch
  • MarginsOperating margin expanded 1170 bps to -11.47%OK
  • AccountingDistress-range screen needs contextWatch
  • Insiders11 purchases and 1 salesOK

Business

Dentsply Sirona develops and sells dental equipment, consumables, technologies and related products to dental professionals and laboratories.

Where the revenue comes from

Fiscal 2025, as DENTSPLY SIRONA Inc. reports it. History and quarterly detail are in the app.

  • Essential Dental Solutions$1.5B
  • Connected Technology Solutions$1.0B
  • Orthodontic and Implant Solutions$850.0M
  • Wellspect Healthcare$325.0M

Leadership changes

From DENTSPLY SIRONA Inc.'s own filings, the day they're filed.

  • John C. Fortson · Chief Financial Officer · appointmenteff. 2026-07-20
  • James D. Forbes · directors · appointmenteff. 2026-02-27
  • Daniel T. Scavilla · Chief Executive Officer · appointmenteff. 2025-11-05

Latest filings

  • 10-Q · Quarterly report2026-08-06
  • 8-K · Company announcement2026-08-06
  • 8-K · Company announcement2026-06-11
  • 8-K · Company announcement2026-06-04
  • 10-Q · Quarterly report2026-05-05
In the full recordFree for 14 days
  • What changed🔒
  • Insider signal🔒
  • Growth quality🔒
  • Margins & accounting🔒
  • Capital allocation🔒
  • Real risks🔒
  • The long arc🔒
  • Company history🔒
  • The filings, readable — with what changed vs the prior year highlighted🔒
  • Full financial statements, industry-aware, sources cited throughout🔒
  • Forensic score history & components — the trend, not one year🔒
  • Ownership: insider buys/sells, clusters, activist stakes🔒
  • Ana — ask about DENTSPLY SIRONA Inc., every answer cited to the official filings🔒

Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.

14-day free trial, no credit card. For research purposes only; not investment advice.